Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study
Overview of attention for article published in Gastroenterology, September 2023
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (98th percentile)
-
High Attention Score compared to outputs of the same age and source (92nd percentile)
Mentioned by
- news
- 14 news outlets
- 24 X users
- patent
- 2 patents
- 1 Facebook page
- 1 Redditor
- guideline
- 3 clinical guideline sources
Readers on
- mendeley
- 70 Mendeley